United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), antimony potassium tartrate (unii: dl6oz476v3) (antimony cation (3+) - unii:069647rpt5), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), drosera rotundifolia - formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, dryness and painful breathing. formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, dryness and painful breathing.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), antimony potassium tartrate (unii: dl6oz476v3) (antimony cation (3+) - unii:069647rpt5), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), drosera rotundifolia - formulated for symptoms such as wheeing, shortness of breath, congestion, coughing, dryness and painful breathing. formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, dryness and painful breathing.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), antimony potassium tartrate (unii: dl6oz476v3) (antimony cation (3+) - unii:069647rpt5), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), drosera rotundifolia flowe - influenza a virus 30 [hp_x] in 1 g - formulated for symptoms such as wheeing, shortness of breath, congestion, coughing, dryness and painful breathing. cough - airway formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, dryness and painful breathing.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), antimony potassium tartrate (unii: dl6oz476v3) (antimony cation (3+) - unii:069647rpt5), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), drosera rotundifolia flowe - influenza a virus 30 [hp_x] in 1 ml - formulated for symptoms such as coughing, shortness of breath, congestion, dryness, painful breathing and wheezing. cough - asthma formulated for symptoms such as coughing, shortness of breath, congestion, dryness, painful breathing and wheezing.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), antimony potassium tartrate (unii: dl6oz476v3) (antimony cation (3+) - unii:069647rpt5), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), drosera rotundifolia flowe - influenza a virus 30 [hp_x] in 1 ml - formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, dryness and painful breathing. cough - airway formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, dryness and painful breathing.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), antimony potassium tartrate (unii: dl6oz476v3) (antimony cation (3+) - unii:069647rpt5), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), drosera rotundifolia - influenza a virus 30 [hp_x] in 1 ml - cough - airway formulated for symptoms such as coughing, wheezing, congestion and labored breathing. formulated for symptoms such as coughing, wheezing, congestion and labored breathing.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), antimony potassium tartrate (unii: dl6oz476v3) (antimony cation (3+) - unii:069647rpt5), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), drosera rotundifolia flowe - formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, inflammation and other related symptoms. airway ease: formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, inflammation and other related symptoms.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), antimony potassium tartrate (unii: dl6oz476v3) (antimony cation (3+) - unii:069647rpt5), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), drosera rotundifolia flowe - formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, inflammation and other related symptoms. airway ease: formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, inflammation and other related symptoms.

United States - English - NLM (National Library of Medicine)

novartis vaccines and diagnostics ltd - influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (propiolactone inactivated) (unii: k9p8pva2ug) (influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (propiolactone inactivated) - unii:k9p8pva2ug) - influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (propiolactone inactivated) 15 ug in 0.5 ml - influenza a (h1n1) 2009 monovalent vaccine is an inactivated influenza virus vaccine indicated for immunization of persons 4 years of age and older against influenza disease caused by pandemic (h1n1) 2009 virus. influenza a (h1n1) 2009 monovalent vaccine should not be administered to anyone with known systemic hypersensitivity reactions to egg proteins (eggs or egg products), or to any component of influenza a (h1n1) 2009 monovalent vaccine, or who has had a life-threatening reaction to previous influenza vaccinations [see description (11)]. novartis’ influenza a (h1n1) 2009 monovalent vaccine and seasonal trivalent influenza virus vaccine (fluvirin) are manufactured by the same process. available information for fluvirin is provided in this section. pregnancy category c: animal reproduction studies have not been conducted with influenza a (h1n1) 2009 monovalent vaccine or fluvirin. it is also not known whether influenza a (h1n1) 2009 monovalent vaccine or fluvirin can cause fetal harm when administered to

United States - English - NLM (National Library of Medicine)

sanofi pasteur inc. - influenza a virus a/california/7/2009(h1n1)-like antigen (formaldehyde inactivated) (unii: 5i5hvc73i8) (influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (formaldehyde inactivated) - unii:euj84un96z) - influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (formaldehyde inactivated) 15 ug in 0.5 ml - influenza a (h1n1) 2009 monovalent vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 6 months of age and older against influenza disease caused by pandemic (h1n1) 2009 virus. do not administer influenza a (h1n1) 2009 monovalent vaccine to anyone with a known severe hypersensitivity to egg proteins or any component of the vaccine or life-threatening reactions after previous administration of any influenza vaccine. [see warnings and precautions (5) and description (11) ] sanofi pasteur's influenza a (h1n1) 2009 monovalent vaccine and seasonal trivalent influenza virus vaccine (fluzone vaccine) are manufactured by the same process. available information for fluzone vaccine is provided in this section. pregnancy category c: animal reproduction studies have not been conducted with influenza a (h1n1) 2009 monovalent vaccine or fluzone vaccine. it is also not known whether these vaccines can cause fetal harm when administered to a pregnant woman or can affect reproduction